CD ComputaBio provides comprehensive peptide virtual screening services, utilizing state-of-the-art computational methods and models to efficiently evaluate and screen large libraries of peptide molecules. We assist clients in identifying candidate peptides that are not only biologically active but also capable of interacting with specific targets with high affinity and specificity.
Peptides attract attention for their involvement in regulating a multitude of biological processes, as peptide epitopes mediate a range of protein-protein interactions (PPIs). Computational methods are undoubtedly helpful in predicting bioactive peptides that can bind with high affinity and specificity to protein targets and block crucial PPIs. By using advanced computational methods and algorithms, peptide virtual screening can quickly predict peptide hits, providing a solid data foundation for subsequent experimental research.
Fig. 1 Peptide virtual screening framework and applications. (Xue B, et al.; 2024)
With outstanding professional expertise, CD ComputaBio provides advanced peptide virtual screening services for the fields of scientific research and drug development, customizing personalized screening solutions based on the specific needs of our clients. We efficiently screen libraries of known peptides or constructed peptide libraries to identify potential candidate peptides with high-affinity binding to specific targets.
Fig.2 CD ComputaBio's peptide virtual screening protocol.
In drug discovery, virtual screening can quickly support the identification of the most promising peptide hits. Virtual screening methods can be primarily divided into two categories: structure-based virtual screening and ligand-based virtual screening.
Structure-based Virtual Screening
Structure-based virtual screening is used to identify and optimize candidate peptides for biological targets. This method utilizes the 3D structure of the targeted protein to screen and design peptides with high affinity and specificity.
Ligand-based Virtual Screening
Ligand-based virtual screening instead employs active ligands as prototypes to target protein receptors. The approach emphasizes the selection of candidate molecules, considering that peptide interactors similar to bioactive peptide ligands possess higher biological activity.
CD ComputaBio's peptide virtual screening services offer customized solutions to meet the unique needs of each client, thereby driving innovation in peptide-based drug development. Please feel free to contact us to discuss your project requirements and how we can leverage our expertise and resources to support your research and development efforts.
References:
CD ComputaBio offers computation-driven peptide design services to research institutions, pharmaceutical, and biotechnology companies.